Preclinical evidence supports the role of GLP-1RAs in alleviating neuropathic pain through the modulation of microglial activity, inflammatory cytokine production and -endorphin release [63, 65, 68, 70,71,72,73,74]
Pregnancy and breastfeeding: Tirzepatide is not recommended during pregnancy and breastfeeding, and the drug should be discontinued at least one month before women attempt to conceive
With a specific focus on dietary restriction, insulin administration and the insulin-lowering drug diazoxide, such modifications of the insulin/IGF-1 system are the topic of this review
Theres no evidence that probiotics can raise GLP-1 levelsor activate its receptorswith anything close to the same strength or duration
The product is not designed for human or veterinary administration and should not be used outside scientific modeling frameworks